|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Warner Chilcott Ltd (WCRX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
40 |
|
|
Total
Direct Shares :
|
104,362,452 |
|
Total
Indirect Shares :
|
246,883,156 |
|
%
Held by Insiders:
|
41.08% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Pagliuca Stephen G |
Director, 10% Owner |
|
0 |
2006-09-21 |
38,045,413 |
Bain Capital Investors Llc |
10% Owner |
|
0 |
2006-09-21 |
38,045,413 |
Thl Wc (cayman), L.p. |
10% Owner |
|
0 |
2010-07-29 |
33,819,264 |
Thl Advisors Alternative V Lp |
10% Owner |
|
0 |
2009-11-25 |
33,151,823 |
Bcip Trust Associates Iii-B |
10% Owner |
2009-11-19 |
0 |
2011-03-10 |
32,877,566 |
Murray Stephen |
Director |
2009-11-25 |
0 |
2011-03-16 |
25,957,812 |
Thomas H Lee Advisors Alternative V Ltd Ldc |
10% Owner |
|
0 |
2012-09-11 |
11,491,622 |
Abbrecht Todd M |
Director |
|
0 |
2012-09-11 |
11,491,622 |
Bain Capital (wc) Netherlands B.v |
10% Owner |
2011-03-16 |
0 |
2012-09-11 |
11,491,622 |
Credit Suisse First Boston |
10% Owner |
|
0 |
2010-09-30 |
10,225,584 |
Reichel W Carl |
President, Pharmaceuticals |
2011-12-31 |
310,082 |
2011-12-31 |
143,016 |
Bruno Anthony D |
Exec. V.P., Corp. Development |
2011-03-30 |
308,123 |
2011-03-30 |
142,399 |
Murray Stephen P |
Director |
|
0 |
2012-11-28 |
0 |
Connaughton John |
Director |
|
0 |
2013-03-04 |
0 |
Burgstahler David F |
Director |
2008-03-07 |
20,000 |
2007-03-12 |
0 |
Alpinvest Partners Later Stage Co-Investments Cust |
*See Remarks, 10% Owner |
2010-09-27 |
0 |
2009-11-25 |
0 |
Fawzi Mahdi B |
President, Research & Develop. |
2011-10-21 |
57,755 |
2009-10-20 |
0 |
J.p. Morgan Partners Global Investors (cayman/sell |
10% Owner |
2012-09-11 |
675,209 |
2011-03-16 |
0 |
Jpmp Capital Corp |
10% Owner |
2012-09-11 |
675,209 |
2011-03-16 |
0 |
Hara Izumi |
Senior V.P. |
2012-12-31 |
43,026 |
2006-09-21 |
0 |
Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
2013-04-01 |
144,838 |
2010-01-29 |
0 |
Howson Tamar D |
Director |
2013-09-30 |
0 |
2013-05-07 |
0 |
King John A |
Director |
2013-09-30 |
0 |
2013-10-01 |
0 |
Vincze Leslie Stephan |
SVP, Chief Compliance Officer |
2013-09-30 |
0 |
2013-07-01 |
0 |
Osullivan Patrick J |
Director |
2013-09-30 |
0 |
2013-05-07 |
0 |
Boissonneault Roger M |
CEO & President, Director |
2013-10-01 |
0 |
2013-10-01 |
0 |
Bloem James H |
Director |
2013-10-01 |
0 |
2006-08-20 |
0 |
Fuhrmann Rochelle |
Senior V.P., Finance |
2013-10-01 |
0 |
2011-01-21 |
0 |
Herendeen Paul |
Exec. V.P. and CFO, Director |
2013-10-01 |
0 |
2006-09-21 |
0 |
Cross Leland H |
Senior V.P. |
2013-10-01 |
0 |
2006-09-21 |
0 |
Gilligan Claire A |
Senior V.P., Quality |
2013-10-01 |
0 |
2013-10-01 |
0 |
Howard Alvin D |
Sr. V.P., Regulatory Affairs |
2013-10-01 |
0 |
2006-09-21 |
0 |
Ellman Herman |
Senior V.P., Clinical Devel. |
2013-10-01 |
0 |
2006-09-21 |
0 |
Fitzgerald Liam M. |
|
|
0 |
|
0 |
Jp Morgan Partners Global Investors Selldown Cayma |
10% Owner |
2006-09-21 |
76,090,808 |
|
0 |
Thomas H Lee Alternative Fund V Lp |
10% Owner |
2009-11-25 |
26,037,402 |
|
0 |
Halstead Michael |
Senior V.P., Corp. Development |
2013-10-01 |
0 |
|
0 |
Rodriguez Rama Francisco |
Senior V.P., Tech. Operations |
2013-10-01 |
0 |
|
0 |
Sullivan Ryan T |
VP, General Counsel & Secr. |
2013-10-01 |
0 |
|
0 |
Fenton Andrew |
Senior V.P., CIO |
2013-10-01 |
0 |
|
0 |
|
|